ENTITY

Tenax Therapeutics (TENX US)

4
Analysis
Health Care • United States
Tenax Therapeutics, Inc. operates as a specialty pharmacuitical company. The Company develops and commercializes products for the critical care market. Tenax Therapeutics develops treatments for treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF) using levosimendan.
more
Company Event • 13 Nov 2026 01:30 • Upcoming
Add To Calendar

Q3 2026

Company Event • 09 Sep 2026 20:35 • Latest

12th Annual Cantor Fitzgerald Global Healthcare Conference

Company Event • 10 Aug 2026 20:00

Study result

Company Event • 31 Jul 2026 19:30 • Upcoming
Add To Calendar

Q2 2026

Company Event • 12 May 2026 20:00 • Upcoming
Add To Calendar

Q1 2026

x